Sign in
4

Changes in Ownership

BIO-TECHNE Corp Filed Acc 0000914190-20-000251

Options or other derivatives

  • Pres. Diagnostics & Genom acquired 39,644 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Kelderman Kim · Pres. Diagnostics & Genom

Table II: Derivative

5 lines
Date Transaction Shares Owned after D/I
2020-08-05 Grant or award : show line 1 in the form Restricted Stock Units +2,015 2,015 D
2020-08-05 Grant or award : show line 2 in the form Stock Options (Right to Buy) +8,991 8,991 D
2020-08-05 Grant or award : show line 3 in the form Stock Options (Right to Buy) +11,988 11,988 D
2020-08-05 Grant or award : show line 4 in the form Stock Options (Right to Buy) +8,325 8,325 D
2020-08-05 Grant or award : show line 5 in the form Stock Options (Right to Buy) +8,325 8,325 D
Loading xslF345X03/edgar.xml…